PowerPoint Presentation
Scene 1 (0s)
1. HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. Gwfqvb Bbd¬z‡qb&Rv fv Bivm.
Scene 2 (25s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. Bbd¬z‡qb&Rv fv Bivm.
Scene 3 (40s)
Type A Influenza Virus Avian, human, mammalian Pandemics Type B Influenza Virus Human, causes epidemics disease similar to type A Type C Influenza Virus Humans, swine Mild infections.
Scene 4 (1m 1s)
HIO H12 H16 nans Wild inb TigerslCats Whales %als Poultry •Exp«iNttily H.tms Center for Foot Security art Healt Iowa State unverstj, 218.
Scene 5 (1m 20s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. Highly pathogenic AI (HPAI) virus or Low pathogenic AI (LPAI) virus..
Scene 6 (1m 37s)
Low pathogenicity avian influenza (LPAI) by H1-4, H6, H8-16.
Scene 7 (1m 55s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. HPAI.
Scene 8 (2m 19s)
HliV-3H IVWINV VIVN-3U JO pueuq e. Fowl plague Avian Flu.
Scene 9 (2m 28s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. Gwfqvb Bbd¬z‡qb&Rv / evW © d¬z Low pathogenicity avian influenza (LPAI) High pathogenicity avian influenza (HPAI) AvµvšÍ Zš ¿ k^mb Zš ¿ I cwicvK Zš ¿ ‡`‡ ni mKj Zš ¿ Morbidity/ Mortality Morbidity-100% Mortality-100% ‡ Kvb † Kvb HA Any HA H5 & H7.
Scene 10 (2m 46s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. Avian Influenza Control.
Scene 11 (2m 52s)
h‡_ó bq Gwfqvb Bbd¬z‡qb&Rv. H9N2. HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e.
Scene 12 (3m 7s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. Avian Influenza Virus Vaccines.
Scene 13 (3m 16s)
[Audio] H9N2 viruses are often found co-circulating in poultry with other AIV subtypes, such as H5 and H7 HPAIVs. There is good evidence to suggest that prior or concurrent H9N2 infection can mask the high mortality rate due to these viruses allowing 'silent' spread of HPAIVs, thwarting surveillance and subsequent intervention efforts..
Scene 14 (3m 41s)
100 — NgnVac — NgnVac — — Vac. Production & mortality curve of a non-vaccinated & vaccinated flock.
Scene 15 (4m 2s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. Inactivated whole-virus vaccines Vector Vaccines Replication-Competent Vector Vaccines P ox virus Herpes Virus ILTV HVT MDV.
Scene 16 (4m 23s)
[Audio] In Bangladesh, highly pathogenic H5N1 virus was first detected on 15 March 2007..
Scene 17 (4m 42s)
HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e. evsjv ‡`‡k Gwfqvb Bbd¬z‡qb&Rv f ¨vKwmb AIV sub-type H5N1 (high pathogenic) Vaccine AIV sub-type H9N2 (low pathogenic) Vaccine.
Scene 18 (4m 54s)
Name of vaccine Type of vaccine Company Cevac New Flu H9 k Inactivated H9N2 & ND ACI.
Scene 19 (5m 18s)
nu!AY uoxxen i i i sn-tsaa. HliV3H IVWINV VIVN-38 enouu.•x: JO pueuq e.
Scene 20 (5m 28s)
eªqjvi : 0.25 wgwj GKw`b eq‡m ev 1-14 w`b eq‡m. ‡ mvbvjx / †` wk † gviM-gyiMx : 1g f ¨vKwm ‡bkb : 0.25 wgwj GKw`b eq‡m ev 1-14 w`b eq‡m 2q f ¨vKwm ‡bkb : 0.5 wgwj 5g mßv‡n.
Scene 21 (6m 0s)
[Audio] IZO inactivated vaccines are produced by turbo emulsion, which technologically and scientifically is the most advanced manufacturing process on the market. It's a water-in-oil emulsion ( more refining form of oil emulsion) with very few and homogeneous droplets..
Scene 22 (6m 29s)
H9N2. Name of vaccine Company Dose TP MRP Vaxxon Aviflu Renata Ltd. 1000 4200.00 4505.00 Nobilis H9N2 Influenza Bengal Overseas Ltd. 1000 4470.00 Cevac New Flu H9 k ACI 1000 5970.00 6300.00.